Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India Article

Puri, Raman, Mehta, Vimal, Duell, P Barton et al. Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India . JOURNAL OF CLINICAL LIPIDOLOGY, 16(3), 261-271. 10.1016/j.jacl.2022.03.008

International Collaboration

cited authors

  • Puri, Raman; Mehta, Vimal; Duell, P Barton; Iyengar, SS; Yusuf, Jamal; Dalal, Jamshad; Narasingan, SN; Kalra, Dinesh; Kapoor, Aditya; Pradhan, Akshaya; Mukhopadhyay, Saibal; Vijayaraghavan, Krishnaswami; Aggarwal, Rajeev; Muruganathan, A; Prabhakar, D; Misra, Sundeep; Shetty, Sadanand; Kasliwal, Ravi R; Bansal, Manish; Khanna, N; Khan, Aziz; Melinkeri, Rashida Patanwala; Kumar, Soumitra; Chakraborty, Rabindra Nath; Bardoloi, Neil; Sahoo, Prasant; Vinayagam, Palaniappen; Modi, Ranjan; Nanda, Rashmi; Wong, Nathan D

sustainable development goals

authors

published in

keywords

  • Acute coronary syndrome
  • Alirocumab
  • CONSENSUS STATEMENT
  • DENSITY-LIPOPROTEIN CHOLESTEROL
  • DISEASE
  • EFFICACY
  • Evolocumab
  • Ezetimibe
  • Life Sciences & Biomedicine
  • Lipoprotein(a)
  • Low density lipoprotein cholesterol (LDL-C)
  • METAANALYSIS
  • MONOCLONAL-ANTIBODIES
  • PCSK9
  • PCSK9 INHIBITOR EVOLOCUMAB
  • PRESPECIFIED ANALYSIS
  • Pharmacology & Pharmacy
  • Recommendations
  • SAFETY
  • STATIN THERAPY
  • Science & Technology
  • Statins

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 261

end page

  • 271

volume

  • 16

issue

  • 3